{"schema_version":"secwatch.filing_event.v1","accession":"0000896264-25-000175","form_type":"8-K","ticker":"USNA","cik":"0000896264","company_name":"USANA HEALTH SCIENCES INC","filed_at":"2025-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.634533+00:00","generated_at":"2026-05-18T11:43:03.139043+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"USANA enters $75M revolving credit facility with Bank of America, $200M accordion option","bullets":["New $75M revolver replaces prior agreement; includes $200M accordion feature subject to conditions.","Interest on Term SOFR loans at Term SOFR plus 1.75%; commitment fee 0.25%.","Financial covenants: minimum consolidated EBITDA of $80M (step-up to $100M after Q3 2026) and funded debt/EBITDA ≤ 2.0x.","No restrictions on cash dividends or share repurchases under the credit agreement.","Obligations secured by pledge of capital stock of subsidiaries via Amended and Restated Security and Pledge Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0000896264-25-000175","json":"https://secwatch.observer/filing/0000896264-25-000175.json","markdown":"https://secwatch.observer/filing/0000896264-25-000175.md","text":"https://secwatch.observer/filing/0000896264-25-000175.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896264/000089626425000175/0000896264-25-000175-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896264/000089626425000175/usna-20250627.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T11:43:03.139043+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2dc78e1a5f295e5bf69dfa59b105ca0801e4d9f3","claim":"USANA HEALTH SCIENCES INC amended revolving credit of up to $75 million with Bank of America, N.A. at Term SOFR plus the applicable margin.","evidence_excerpt":"Swingline Lender and Letter of Credit Issuer, and the other lenders party thereto. The Credit Agreement provides for a revolving credit limit for loans to the Company of up to $75 million (the “Credit Facility”). In addition, at the option of the Company, and subject to certain conditions, the Company may request to increase the aggregate commitment under the","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/896264/000089626425000175/0000896264-25-000175-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"up to $75 million"},{"label":"Counterparty","value":"Bank of America, N.A."},{"label":"Rate","value":"Term SOFR plus the applicable margin"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}